News
RNLXY
1.110
-7.50%
-0.090
Weekly Report: what happened at RNLXY last week (0511-0515)?
Weekly Report · 4d ago
Renalytix partners with Carna Health on CKD screening, precision care model
PUBT · 05/12 11:43
Weekly Report: what happened at RNLXY last week (0504-0508)?
Weekly Report · 05/11 10:28
Weekly Report: what happened at RNLXY last week (0427-0501)?
Weekly Report · 05/04 10:25
Weekly Report: what happened at RNLXY last week (0420-0424)?
Weekly Report · 04/27 10:28
Weekly Report: what happened at RNLXY last week (0413-0417)?
Weekly Report · 04/20 10:24
Weekly Report: what happened at RNLXY last week (0406-0410)?
Weekly Report · 04/13 10:28
Weekly Report: what happened at RNLXY last week (0330-0403)?
Weekly Report · 04/06 10:28
Weekly Report: what happened at RNLXY last week (0323-0327)?
Weekly Report · 03/30 10:29
Weekly Report: what happened at RNLXY last week (0316-0320)?
Weekly Report · 03/23 10:25
Weekly Report: what happened at RNLXY last week (0309-0313)?
Weekly Report · 03/16 10:24
Weekly Report: what happened at RNLXY last week (0302-0306)?
Weekly Report · 03/09 10:24
Weekly Report: what happened at RNLXY last week (0223-0227)?
Weekly Report · 03/02 10:23
Weekly Report: what happened at RNLXY last week (0216-0220)?
Weekly Report · 02/23 10:23
Weekly Report: what happened at RNLXY last week (0209-0213)?
Weekly Report · 02/16 10:23
Renalytix Interim CFO Joel Jung Purchases 500 ADS in Company
Reuters · 02/13 12:15
Weekly Report: what happened at RNLXY last week (0202-0206)?
Weekly Report · 02/09 10:25
Weekly Report: what happened at RNLXY last week (0126-0130)?
Weekly Report · 02/02 10:25
Weekly Report: what happened at RNLXY last week (0119-0123)?
Weekly Report · 01/26 10:24
Weekly Report: what happened at RNLXY last week (0112-0116)?
Weekly Report · 01/19 10:31
More
Webull provides a variety of real-time RNLXY stock news. You can receive the latest news about Renalytix Plc through multiple platforms. This information may help you make smarter investment decisions.
About RNLXY
Renalytix plc is a United Kingdom-based company, which is engaged in the development of artificial intelligence-enabled clinical diagnostic solutions for kidney disease. The Company is engaged in a field of bioprognosis for kidney health. The Company has engineered a solution that enables early-stage chronic kidney disease progression risk assessment. KidneyIntelX, is a vitro diagnostic platform, employs a proprietary algorithm that combines diverse data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data from electronic health record or EHR, systems, to generate a patient risk score. KidneyIntelX has been granted designation by the United States Food and Drug Administration and is designed to help make significant improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.